rs2140287858
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_014249.4(NR2E3):c.50_51insAG(p.Pro18GlyfsTer25) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Synonymous variant affecting the same amino acid position (i.e. A17A) has been classified as Likely benign.
Frequency
Consequence
NM_014249.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- retinitis pigmentosa 37Inheritance: AD, AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- enhanced S-cone syndromeInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Goldmann-Favre syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_014249.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| NR2E3 | TSL:1 MANE Select | c.50_51insAG | p.Pro18GlyfsTer25 | frameshift | Exon 1 of 8 | ENSP00000482504.1 | Q9Y5X4-1 | ||
| NR2E3 | TSL:1 | c.50_51insAG | p.Pro18GlyfsTer25 | frameshift | Exon 1 of 7 | ENSP00000479962.1 | Q9Y5X4-2 | ||
| NR2E3 | TSL:2 | c.-146-690_-146-689insAG | intron | N/A | ENSP00000479254.1 | Q8IVZ9 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at